Publications by authors named "Dale Gerding"

Claim this Profile
H
How to develop a controlled human infection model for Clostridioides difficile.
Annefleur D O Hensen, Maria J G T Vehreschild, Dale N Gerding, Oleg Krut, Wilbur Chen

Clin Microbiol Infect· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Controlled Trial of Efficacy and Safety of Fecal Microbiota Transplant for Preventing Recurrent Clostridioides difficile Infection.
Dimitri M Drekonja, Aasma Shaukat, Yuan Huang, Jane H Zhang, Andrew R Reinink, Dale N Gerding

Clin Infect Dis· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The End of Toxoid Vaccine Development for Preventing Clostridioides difficile Infections?
Ed J Kuijper, Dale N Gerding

Clin Infect Dis· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epidemiology of infection at one hospital 10 years after an outbreak of the epidemic strain BI/027: changing strain prevalence, antimicrobial susceptibilities, and patient antibiotic exposures.
Jeffrey T Wieczorkiewicz, Andrew M Skinner, Adam Cheknis, Laurica A Petrella, Vanessa W Stevens, Dale N Gerding

Antimicrob Agents Chemother· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Potential underreporting of treated patients using a testing algorithm that screens with a nucleic acid amplification test.
Alice Y Guh, Scott Fridkin, Dana Goodenough, Lisa G Winston, Helen Johnston, Dale N Gerding

Infect Control Hosp Epidemiol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics of Patients With Initial Infection (CDI) That Are Associated With Increased Risk of Multiple CDI Recurrences.
Alice Y Guh, Rongxia Li, Lauren Korhonen, Lisa G Winston, Erin Parker, Dale N Gerding

Open Forum Infect Dis· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is the Healthcare Facility Level Sufficient for Assessing the Impact of 2-Step Clostridioides difficile Testing?
Dale N Gerding

Clin Infect Dis· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Executive Summary: A Compendium of Strategies to Prevent Healthcare-Associated Infections in Acute-Care Hospitals: 2022 Updates.
Deborah S Yokoe, Sonali D Advani, Deverick J Anderson, Hilary M Babcock, Michael Bell, Dale N Gerding

Infect Control Hosp Epidemiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Introduction to .
Deborah S Yokoe, Sonali D Advani, Deverick J Anderson, Hilary M Babcock, Michael Bell, Dale N Gerding

Infect Control Hosp Epidemiol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
To treat or not to treat: infection (CDI) guidelines, diagnostic algorithms, and CDI reporting.
Dale N Gerding

Infect Control Hosp Epidemiol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redefining Clostridioides difficile infection antibiotic response and clinical outcomes.
Anne J Gonzales-Luna, Andrew M Skinner, Carolyn D Alonso, Emilio Bouza, Oliver A Cornely, Dale N Gerding

Lancet Infect Dis· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of the COVID-19 Pandemic on Rates and Epidemiology of Infection in One VA Hospital.
Lorinda M Wright, Andrew M Skinner, Adam Cheknis, Conor McBurney, Ling Ge, Dale N Gerding

Antibiotics (Basel)· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strategies to prevent infections in acute-care hospitals: 2022 Update.
Larry K Kociolek, Dale N Gerding, Ruth Carrico, Philip Carling, Curtis J Donskey

Infect Control Hosp Epidemiol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effective Colonization by Nontoxigenic Clostridioides difficile REA Strain M3 (NTCD-M3) Spores following Treatment with Either Fidaxomicin or Vancomycin.
Susan P Sambol, Andrew M Skinner, Fidel Serna-Perez, Benjamin Owen, Dale N Gerding

Microbiol Spectr· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of the Risk of Recurrent Infections Among Patients in 2018 Versus 2013.
Alice Y Guh, Sarah H Yi, James Baggs, Lisa Winston, Erin Parker, Dale N Gerding

Open Forum Infect Dis· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Absence of toxin gene transfer from Clostridioides difficile strain 630Δerm to nontoxigenic C. difficile strain NTCD-M3r in filter mating experiments.
Susan P Sambol, Stuart Johnson, Adam Cheknis, Dale N Gerding

PLoS One· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining optimal treatment for recurrent Clostridioides difficile infection (OpTION study): A randomized, double-blind comparison of three antibiotic regimens for patients with a first or second recurrence.
Stuart Johnson, Dale N Gerding, Xue Li, Domenic J Reda, Curtis J Donskey

Contemp Clin Trials· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Durable reduction of Clostridioides difficile infection recurrence and microbiome restoration after treatment with RBX2660: results from an open-label phase 2 clinical trial.
Robert Orenstein, Erik R Dubberke, Sahil Khanna, Christine H Lee, David Yoho, Dale N Gerding

BMC Infect Dis· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Host Immune Responses to : Toxins and Beyond.
Britt Nibbering, Dale N Gerding, Ed J Kuijper, Romy D Zwittink, Wiep Klaas Smits

Front Microbiol· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Bezlotoxumab in Trial Participants Infected With Clostridioides difficile Strain BI Associated With Poor Outcomes.
Stuart Johnson, Diane M Citron, Dale N Gerding, Mark H Wilcox, Ellie J C Goldstein

Clin Infect Dis· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microbiota or placebo after antimicrobial therapy for recurrent at home: A clinical trial with novel home-based enrollment.
Dimitri M Drekonja, Aasma Shaukat, Jane H Zhang, Andrew R Reinink, Sean Nugent, Dale N Gerding

Clin Trials· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Tapered-pulsed Fidaxomicin Regimen Following Treatment in Patients With Multiple Clostridioides difficile Infection Recurrences.
Andrew M Skinner, Xing Tan, Benjamin D Sirbu, Larry H Danziger, Dale N Gerding

Clin Infect Dis· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of patients at risk of Clostridioides difficile infection for enrollment in vaccine clinical trials.
Vanessa W Stevens, Ellyn M Russo, Yinong Young-Xu, Molly Leecaster, Yue Zhang, Dale N Gerding

Vaccine· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Relative Role of Toxins A and B in the Virulence of .
Andrew M Skinner, S Tyler Phillips, Michelle M Merrigan, Kevin J O'Leary, Susan P Sambol, Dale N Gerding

J Clin Med· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential introduction of a multistep testing algorithm and nucleic acid amplification testing leading to an increase in detection and a trend toward increased strain diversity.
Andrew M Skinner, Brian Yu, Adam Cheknis, Susan M Pacheco, Dale N Gerding

Infect Control Hosp Epidemiol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis